N-(5,6-dimethoxy-1,3-benzothiazol-2-yl)-N-methylglycine, 95.0%, 500mg

N-dodecylaniline, 93.0%, 5g

(R)-3-Amino-4-phenylbutyric acid hydrochloride, 95.0%, 250mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-fluorophenyl)propanoic acid, 97%, 5g

Methyl 4-amino-1H-pyrazole-3-carboxylate, 95.0%, 5g

Morpholine-2-carboxylic acid, 95.0%, 1g

3-Amino-3-(4-fluorophenyl)propionic Acid>98.0%(HPLC)(T)1g

Pyrazolo[2,3-a]pyrimidine, 95.0%, 1g

Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, 98%, 500g

N-(4-Bromophenyl)maleimide, 97.0%, 25g

(2-Bromo-6-nitrophenyl)methanol, 95.0%, 100g

GC capillary column ROTI®Cap-5 MS Ultra, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

2,3-Dimethyl-1,3-benzothiazol-3-ium Iodide>98.0%(HPLC)(T)25g